Concepedia

Evdoxia Hatjiharissi

EH

43

Publications

3K

Citations

27

H-Index

2002

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

National and Kapodistrian University of Athens

AHEPA University Hospital

Theageneio General Hospital

Evdoxia Hatjiharissi is an author at Dana-Farber Cancer Institute specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2002–2024

43

Publications

43

Soluble receptor activator of nuclear factor κB ligand–osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index

Evangelos Terpos, Richard Szydlo, Jane F. Apperley et al. · Blood · 2003 · 410 citations · Full text

Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the FcγRIIIa-158 V/V and V/F polymorphism

Evdoxia Hatjiharissi, Lian Xu, Daniel Santos et al. · Blood · 2007 · 260 citations · Full text

Characterization of familial Waldenström's macroglobulinemia

Steven P. Treon, Zachary R. Hunter, Abha Aggarwal et al. · Annals of Oncology · 2005 · 189 citations

, , +5

Increased Incidence of Transformation and Myelodysplasia/Acute Leukemia in Patients With Waldenström Macroglobulinemia Treated With Nucleoside Analogs

Xavier Leleu, Jacob D. Soumerai, Aldo M. Roccaro et al. · Journal of Clinical Oncology · 2008 · 182 citations · Full text

Thalidomide and rituximab in Waldenstrom macroglobulinemia

Steven P. Treon, Jacob D. Soumerai, Andrew R. Branagan et al. · Blood · 2008 · 143 citations · Full text

Rows per page

1–5 of 43